nodes	percent_of_prediction	percent_of_DWPC	metapath
Estropipate—Exemestane—Prednisone—systemic scleroderma	0.309	1	CrCrCtD
Estropipate—ALB—Captopril—systemic scleroderma	0.0788	0.184	CbGbCtD
Estropipate—CYP1A2—Pentoxifylline—systemic scleroderma	0.0629	0.147	CbGbCtD
Estropipate—ALB—Mycophenolate mofetil—systemic scleroderma	0.062	0.145	CbGbCtD
Estropipate—CYP1A2—Leflunomide—systemic scleroderma	0.06	0.141	CbGbCtD
Estropipate—CYP2C9—Leflunomide—systemic scleroderma	0.0541	0.127	CbGbCtD
Estropipate—ALB—Prednisone—systemic scleroderma	0.0496	0.116	CbGbCtD
Estropipate—ALB—Methotrexate—systemic scleroderma	0.0249	0.0582	CbGbCtD
Estropipate—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0194	0.0455	CbGbCtD
Estropipate—CYP3A4—Prednisone—systemic scleroderma	0.0155	0.0364	CbGbCtD
Estropipate—CYP2C9—cardial valve—systemic scleroderma	0.00919	0.479	CbGeAlD
Estropipate—ESR1—blood vessel—systemic scleroderma	0.00147	0.0765	CbGeAlD
Estropipate—ESR2—connective tissue—systemic scleroderma	0.0011	0.0573	CbGeAlD
Estropipate—SHBG—connective tissue—systemic scleroderma	0.00107	0.0557	CbGeAlD
Estropipate—ESR2—smooth muscle tissue—systemic scleroderma	0.00101	0.0524	CbGeAlD
Estropipate—ESR2—digestive system—systemic scleroderma	0.000794	0.0414	CbGeAlD
Estropipate—ESR1—connective tissue—systemic scleroderma	0.000753	0.0392	CbGeAlD
Estropipate—ESR1—smooth muscle tissue—systemic scleroderma	0.000689	0.0359	CbGeAlD
Estropipate—ESR2—lung—systemic scleroderma	0.000663	0.0345	CbGeAlD
Estropipate—ESR1—digestive system—systemic scleroderma	0.000544	0.0283	CbGeAlD
Estropipate—ESR1—lung—systemic scleroderma	0.000454	0.0237	CbGeAlD
Estropipate—CYP1A2—digestive system—systemic scleroderma	0.000419	0.0218	CbGeAlD
Estropipate—CYP2C9—digestive system—systemic scleroderma	0.000398	0.0207	CbGeAlD
Estropipate—CYP1A2—lung—systemic scleroderma	0.00035	0.0182	CbGeAlD
Estropipate—CYP3A4—digestive system—systemic scleroderma	0.000303	0.0158	CbGeAlD
Estropipate—Palpitations—Lisinopril—systemic scleroderma	0.00024	0.000982	CcSEcCtD
Estropipate—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.00024	0.00098	CcSEcCtD
Estropipate—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000239	0.000978	CcSEcCtD
Estropipate—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000238	0.000974	CcSEcCtD
Estropipate—Cough—Lisinopril—systemic scleroderma	0.000237	0.00097	CcSEcCtD
Estropipate—Visual disturbance—Methotrexate—systemic scleroderma	0.000237	0.000967	CcSEcCtD
Estropipate—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000236	0.000965	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000235	0.000962	CcSEcCtD
Estropipate—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000235	0.00096	CcSEcCtD
Estropipate—Tension—Mycophenolate mofetil—systemic scleroderma	0.000234	0.000956	CcSEcCtD
Estropipate—Insomnia—Leflunomide—systemic scleroderma	0.000234	0.000955	CcSEcCtD
Estropipate—Abdominal distension—Prednisone—systemic scleroderma	0.000233	0.000954	CcSEcCtD
Estropipate—Paraesthesia—Leflunomide—systemic scleroderma	0.000232	0.000948	CcSEcCtD
Estropipate—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.000232	0.000947	CcSEcCtD
Estropipate—Arthralgia—Lisinopril—systemic scleroderma	0.000232	0.000946	CcSEcCtD
Estropipate—Myalgia—Lisinopril—systemic scleroderma	0.000232	0.000946	CcSEcCtD
Estropipate—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000232	0.000946	CcSEcCtD
Estropipate—Anxiety—Lisinopril—systemic scleroderma	0.000231	0.000943	CcSEcCtD
Estropipate—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000231	0.000942	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00023	0.00094	CcSEcCtD
Estropipate—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000229	0.000936	CcSEcCtD
Estropipate—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.000229	0.000935	CcSEcCtD
Estropipate—Dyspepsia—Leflunomide—systemic scleroderma	0.000227	0.000929	CcSEcCtD
Estropipate—Pancreatitis—Prednisone—systemic scleroderma	0.000227	0.000929	CcSEcCtD
Estropipate—Vomiting—Mometasone—systemic scleroderma	0.000227	0.000927	CcSEcCtD
Estropipate—Rash—Mometasone—systemic scleroderma	0.000225	0.00092	CcSEcCtD
Estropipate—Asthenia—Captopril—systemic scleroderma	0.000225	0.000919	CcSEcCtD
Estropipate—Dermatitis—Mometasone—systemic scleroderma	0.000225	0.000919	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000225	0.000918	CcSEcCtD
Estropipate—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000224	0.000914	CcSEcCtD
Estropipate—Headache—Mometasone—systemic scleroderma	0.000224	0.000914	CcSEcCtD
Estropipate—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000223	0.000911	CcSEcCtD
Estropipate—Insomnia—Mycophenolic acid—systemic scleroderma	0.000223	0.000911	CcSEcCtD
Estropipate—Fatigue—Leflunomide—systemic scleroderma	0.000223	0.00091	CcSEcCtD
Estropipate—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000222	0.000907	CcSEcCtD
Estropipate—Oedema—Lisinopril—systemic scleroderma	0.000222	0.000907	CcSEcCtD
Estropipate—Pruritus—Captopril—systemic scleroderma	0.000222	0.000906	CcSEcCtD
Estropipate—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000221	0.000904	CcSEcCtD
Estropipate—Constipation—Leflunomide—systemic scleroderma	0.000221	0.000903	CcSEcCtD
Estropipate—Pain—Leflunomide—systemic scleroderma	0.000221	0.000903	CcSEcCtD
Estropipate—Infection—Lisinopril—systemic scleroderma	0.000221	0.000901	CcSEcCtD
Estropipate—Somnolence—Mycophenolic acid—systemic scleroderma	0.000219	0.000895	CcSEcCtD
Estropipate—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000218	0.00089	CcSEcCtD
Estropipate—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000217	0.000887	CcSEcCtD
Estropipate—Abdominal pain—Azathioprine—systemic scleroderma	0.000216	0.000884	CcSEcCtD
Estropipate—Body temperature increased—Azathioprine—systemic scleroderma	0.000216	0.000884	CcSEcCtD
Estropipate—Skin disorder—Lisinopril—systemic scleroderma	0.000216	0.000881	CcSEcCtD
Estropipate—Diarrhoea—Captopril—systemic scleroderma	0.000215	0.000876	CcSEcCtD
Estropipate—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000214	0.000875	CcSEcCtD
Estropipate—Irritability—Methotrexate—systemic scleroderma	0.000214	0.000874	CcSEcCtD
Estropipate—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000213	0.00087	CcSEcCtD
Estropipate—Fatigue—Mycophenolic acid—systemic scleroderma	0.000213	0.000868	CcSEcCtD
Estropipate—Mood swings—Methotrexate—systemic scleroderma	0.000212	0.000868	CcSEcCtD
Estropipate—Nausea—Mometasone—systemic scleroderma	0.000212	0.000866	CcSEcCtD
Estropipate—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000211	0.000863	CcSEcCtD
Estropipate—Weight increased—Prednisone—systemic scleroderma	0.000211	0.000862	CcSEcCtD
Estropipate—Constipation—Mycophenolic acid—systemic scleroderma	0.000211	0.000861	CcSEcCtD
Estropipate—Pain—Mycophenolic acid—systemic scleroderma	0.000211	0.000861	CcSEcCtD
Estropipate—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000211	0.000861	CcSEcCtD
Estropipate—Hyperglycaemia—Prednisone—systemic scleroderma	0.000209	0.000855	CcSEcCtD
Estropipate—Cough—Mycophenolate mofetil—systemic scleroderma	0.000208	0.00085	CcSEcCtD
Estropipate—Dizziness—Captopril—systemic scleroderma	0.000207	0.000847	CcSEcCtD
Estropipate—Depression—Prednisone—systemic scleroderma	0.000206	0.000842	CcSEcCtD
Estropipate—Urticaria—Leflunomide—systemic scleroderma	0.000205	0.000839	CcSEcCtD
Estropipate—Abdominal pain—Leflunomide—systemic scleroderma	0.000204	0.000835	CcSEcCtD
Estropipate—Body temperature increased—Leflunomide—systemic scleroderma	0.000204	0.000835	CcSEcCtD
Estropipate—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000204	0.000833	CcSEcCtD
Estropipate—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000203	0.000829	CcSEcCtD
Estropipate—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000203	0.000829	CcSEcCtD
Estropipate—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000203	0.000828	CcSEcCtD
Estropipate—Myocardial infarction—Prednisone—systemic scleroderma	0.000203	0.000828	CcSEcCtD
Estropipate—Breast disorder—Methotrexate—systemic scleroderma	0.000203	0.000828	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000202	0.000827	CcSEcCtD
Estropipate—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000202	0.000826	CcSEcCtD
Estropipate—Hypersensitivity—Azathioprine—systemic scleroderma	0.000202	0.000824	CcSEcCtD
Estropipate—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000202	0.000824	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000202	0.000823	CcSEcCtD
Estropipate—Insomnia—Lisinopril—systemic scleroderma	0.000201	0.000821	CcSEcCtD
Estropipate—Paraesthesia—Lisinopril—systemic scleroderma	0.000199	0.000815	CcSEcCtD
Estropipate—Vomiting—Captopril—systemic scleroderma	0.000199	0.000814	CcSEcCtD
Estropipate—Rash—Captopril—systemic scleroderma	0.000198	0.000808	CcSEcCtD
Estropipate—Dermatitis—Captopril—systemic scleroderma	0.000198	0.000807	CcSEcCtD
Estropipate—Somnolence—Lisinopril—systemic scleroderma	0.000197	0.000806	CcSEcCtD
Estropipate—Headache—Captopril—systemic scleroderma	0.000196	0.000803	CcSEcCtD
Estropipate—Dyspepsia—Lisinopril—systemic scleroderma	0.000195	0.000799	CcSEcCtD
Estropipate—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000195	0.000796	CcSEcCtD
Estropipate—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000195	0.000796	CcSEcCtD
Estropipate—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000195	0.000795	CcSEcCtD
Estropipate—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000195	0.000795	CcSEcCtD
Estropipate—Asthma—Methotrexate—systemic scleroderma	0.000194	0.000792	CcSEcCtD
Estropipate—Infection—Mycophenolate mofetil—systemic scleroderma	0.000193	0.00079	CcSEcCtD
Estropipate—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000192	0.000783	CcSEcCtD
Estropipate—Fatigue—Lisinopril—systemic scleroderma	0.000191	0.000782	CcSEcCtD
Estropipate—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000191	0.000779	CcSEcCtD
Estropipate—Hypersensitivity—Leflunomide—systemic scleroderma	0.00019	0.000778	CcSEcCtD
Estropipate—Pancreatitis—Methotrexate—systemic scleroderma	0.00019	0.000776	CcSEcCtD
Estropipate—Constipation—Lisinopril—systemic scleroderma	0.00019	0.000776	CcSEcCtD
Estropipate—Pain—Lisinopril—systemic scleroderma	0.00019	0.000776	CcSEcCtD
Estropipate—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000189	0.000772	CcSEcCtD
Estropipate—Diarrhoea—Azathioprine—systemic scleroderma	0.000187	0.000765	CcSEcCtD
Estropipate—Nausea—Captopril—systemic scleroderma	0.000186	0.000761	CcSEcCtD
Estropipate—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000186	0.000759	CcSEcCtD
Estropipate—Asthenia—Leflunomide—systemic scleroderma	0.000185	0.000757	CcSEcCtD
Estropipate—Pruritus—Leflunomide—systemic scleroderma	0.000183	0.000747	CcSEcCtD
Estropipate—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000182	0.000742	CcSEcCtD
Estropipate—Dysuria—Methotrexate—systemic scleroderma	0.000181	0.00074	CcSEcCtD
Estropipate—Dizziness—Azathioprine—systemic scleroderma	0.000181	0.000739	CcSEcCtD
Estropipate—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.00018	0.000736	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000177	0.000724	CcSEcCtD
Estropipate—Asthenia—Mycophenolic acid—systemic scleroderma	0.000177	0.000723	CcSEcCtD
Estropipate—Diarrhoea—Leflunomide—systemic scleroderma	0.000177	0.000722	CcSEcCtD
Estropipate—Urticaria—Lisinopril—systemic scleroderma	0.000176	0.000721	CcSEcCtD
Estropipate—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000176	0.000719	CcSEcCtD
Estropipate—Abdominal pain—Lisinopril—systemic scleroderma	0.000176	0.000717	CcSEcCtD
Estropipate—Body temperature increased—Lisinopril—systemic scleroderma	0.000176	0.000717	CcSEcCtD
Estropipate—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000175	0.000714	CcSEcCtD
Estropipate—Pruritus—Mycophenolic acid—systemic scleroderma	0.000174	0.000713	CcSEcCtD
Estropipate—Vomiting—Azathioprine—systemic scleroderma	0.000174	0.000711	CcSEcCtD
Estropipate—Eye disorder—Prednisone—systemic scleroderma	0.000173	0.000709	CcSEcCtD
Estropipate—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000173	0.000707	CcSEcCtD
Estropipate—Infestation—Methotrexate—systemic scleroderma	0.000173	0.000706	CcSEcCtD
Estropipate—Infestation NOS—Methotrexate—systemic scleroderma	0.000173	0.000706	CcSEcCtD
Estropipate—Rash—Azathioprine—systemic scleroderma	0.000173	0.000705	CcSEcCtD
Estropipate—Dermatitis—Azathioprine—systemic scleroderma	0.000172	0.000704	CcSEcCtD
Estropipate—Depression—Methotrexate—systemic scleroderma	0.000172	0.000704	CcSEcCtD
Estropipate—Headache—Azathioprine—systemic scleroderma	0.000171	0.0007	CcSEcCtD
Estropipate—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000171	0.0007	CcSEcCtD
Estropipate—Dizziness—Leflunomide—systemic scleroderma	0.000171	0.000698	CcSEcCtD
Estropipate—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000169	0.000689	CcSEcCtD
Estropipate—Angiopathy—Prednisone—systemic scleroderma	0.000168	0.000688	CcSEcCtD
Estropipate—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000168	0.000686	CcSEcCtD
Estropipate—Immune system disorder—Prednisone—systemic scleroderma	0.000168	0.000685	CcSEcCtD
Estropipate—Pain—Mycophenolate mofetil—systemic scleroderma	0.000166	0.00068	CcSEcCtD
Estropipate—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000166	0.00068	CcSEcCtD
Estropipate—Vomiting—Leflunomide—systemic scleroderma	0.000164	0.000671	CcSEcCtD
Estropipate—Alopecia—Prednisone—systemic scleroderma	0.000164	0.00067	CcSEcCtD
Estropipate—Hypersensitivity—Lisinopril—systemic scleroderma	0.000164	0.000668	CcSEcCtD
Estropipate—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000163	0.000668	CcSEcCtD
Estropipate—Dizziness—Mycophenolic acid—systemic scleroderma	0.000163	0.000666	CcSEcCtD
Estropipate—Rash—Leflunomide—systemic scleroderma	0.000163	0.000666	CcSEcCtD
Estropipate—Dermatitis—Leflunomide—systemic scleroderma	0.000163	0.000665	CcSEcCtD
Estropipate—Mental disorder—Prednisone—systemic scleroderma	0.000163	0.000664	CcSEcCtD
Estropipate—Nausea—Azathioprine—systemic scleroderma	0.000163	0.000664	CcSEcCtD
Estropipate—Headache—Leflunomide—systemic scleroderma	0.000162	0.000661	CcSEcCtD
Estropipate—Erythema—Prednisone—systemic scleroderma	0.000162	0.00066	CcSEcCtD
Estropipate—Malnutrition—Prednisone—systemic scleroderma	0.000162	0.00066	CcSEcCtD
Estropipate—Asthenia—Lisinopril—systemic scleroderma	0.000159	0.000651	CcSEcCtD
Estropipate—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000159	0.00065	CcSEcCtD
Estropipate—Pruritus—Lisinopril—systemic scleroderma	0.000157	0.000642	CcSEcCtD
Estropipate—Vomiting—Mycophenolic acid—systemic scleroderma	0.000157	0.00064	CcSEcCtD
Estropipate—Rash—Mycophenolic acid—systemic scleroderma	0.000155	0.000635	CcSEcCtD
Estropipate—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000155	0.000634	CcSEcCtD
Estropipate—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000155	0.000631	CcSEcCtD
Estropipate—Headache—Mycophenolic acid—systemic scleroderma	0.000154	0.000631	CcSEcCtD
Estropipate—Pharyngitis—Methotrexate—systemic scleroderma	0.000154	0.000629	CcSEcCtD
Estropipate—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000154	0.000628	CcSEcCtD
Estropipate—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000154	0.000628	CcSEcCtD
Estropipate—Nausea—Leflunomide—systemic scleroderma	0.000154	0.000627	CcSEcCtD
Estropipate—Diarrhoea—Lisinopril—systemic scleroderma	0.000152	0.000621	CcSEcCtD
Estropipate—Visual impairment—Methotrexate—systemic scleroderma	0.00015	0.000611	CcSEcCtD
Estropipate—Angioedema—Prednisone—systemic scleroderma	0.000148	0.000603	CcSEcCtD
Estropipate—Dizziness—Lisinopril—systemic scleroderma	0.000147	0.0006	CcSEcCtD
Estropipate—Erythema multiforme—Methotrexate—systemic scleroderma	0.000147	0.000599	CcSEcCtD
Estropipate—Nausea—Mycophenolic acid—systemic scleroderma	0.000146	0.000598	CcSEcCtD
Estropipate—Vertigo—Prednisone—systemic scleroderma	0.000145	0.000593	CcSEcCtD
Estropipate—Eye disorder—Methotrexate—systemic scleroderma	0.000145	0.000592	CcSEcCtD
Estropipate—Cardiac disorder—Methotrexate—systemic scleroderma	0.000144	0.000588	CcSEcCtD
Estropipate—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000143	0.000586	CcSEcCtD
Estropipate—Vomiting—Lisinopril—systemic scleroderma	0.000141	0.000577	CcSEcCtD
Estropipate—Angiopathy—Methotrexate—systemic scleroderma	0.000141	0.000575	CcSEcCtD
Estropipate—Immune system disorder—Methotrexate—systemic scleroderma	0.00014	0.000572	CcSEcCtD
Estropipate—Rash—Lisinopril—systemic scleroderma	0.00014	0.000572	CcSEcCtD
Estropipate—Dermatitis—Lisinopril—systemic scleroderma	0.00014	0.000571	CcSEcCtD
Estropipate—Mediastinal disorder—Methotrexate—systemic scleroderma	0.00014	0.000571	CcSEcCtD
Estropipate—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00014	0.00057	CcSEcCtD
Estropipate—Headache—Lisinopril—systemic scleroderma	0.000139	0.000568	CcSEcCtD
Estropipate—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000138	0.000562	CcSEcCtD
Estropipate—Myalgia—Prednisone—systemic scleroderma	0.000138	0.000562	CcSEcCtD
Estropipate—Arthralgia—Prednisone—systemic scleroderma	0.000138	0.000562	CcSEcCtD
Estropipate—Anxiety—Prednisone—systemic scleroderma	0.000137	0.00056	CcSEcCtD
Estropipate—Alopecia—Methotrexate—systemic scleroderma	0.000137	0.00056	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000137	0.000558	CcSEcCtD
Estropipate—Mental disorder—Methotrexate—systemic scleroderma	0.000136	0.000555	CcSEcCtD
Estropipate—Erythema—Methotrexate—systemic scleroderma	0.000135	0.000552	CcSEcCtD
Estropipate—Malnutrition—Methotrexate—systemic scleroderma	0.000135	0.000552	CcSEcCtD
Estropipate—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000133	0.000544	CcSEcCtD
Estropipate—Nausea—Lisinopril—systemic scleroderma	0.000132	0.000539	CcSEcCtD
Estropipate—Oedema—Prednisone—systemic scleroderma	0.000132	0.000539	CcSEcCtD
Estropipate—Anaphylactic shock—Prednisone—systemic scleroderma	0.000132	0.000539	CcSEcCtD
Estropipate—Infection—Prednisone—systemic scleroderma	0.000131	0.000535	CcSEcCtD
Estropipate—Back pain—Methotrexate—systemic scleroderma	0.000131	0.000534	CcSEcCtD
Estropipate—Nervous system disorder—Prednisone—systemic scleroderma	0.000129	0.000528	CcSEcCtD
Estropipate—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000129	0.000526	CcSEcCtD
Estropipate—Skin disorder—Prednisone—systemic scleroderma	0.000128	0.000523	CcSEcCtD
Estropipate—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000124	0.000505	CcSEcCtD
Estropipate—Rash—Mycophenolate mofetil—systemic scleroderma	0.000123	0.000501	CcSEcCtD
Estropipate—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000123	0.000501	CcSEcCtD
Estropipate—Headache—Mycophenolate mofetil—systemic scleroderma	0.000122	0.000498	CcSEcCtD
Estropipate—Vertigo—Methotrexate—systemic scleroderma	0.000121	0.000496	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00012	0.000491	CcSEcCtD
Estropipate—Insomnia—Prednisone—systemic scleroderma	0.000119	0.000487	CcSEcCtD
Estropipate—Paraesthesia—Prednisone—systemic scleroderma	0.000118	0.000484	CcSEcCtD
Estropipate—Cough—Methotrexate—systemic scleroderma	0.000118	0.000481	CcSEcCtD
Estropipate—Dyspepsia—Prednisone—systemic scleroderma	0.000116	0.000474	CcSEcCtD
Estropipate—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000116	0.000472	CcSEcCtD
Estropipate—Arthralgia—Methotrexate—systemic scleroderma	0.000115	0.00047	CcSEcCtD
Estropipate—Myalgia—Methotrexate—systemic scleroderma	0.000115	0.00047	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000114	0.000466	CcSEcCtD
Estropipate—Fatigue—Prednisone—systemic scleroderma	0.000114	0.000465	CcSEcCtD
Estropipate—Constipation—Prednisone—systemic scleroderma	0.000113	0.000461	CcSEcCtD
Estropipate—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00011	0.00045	CcSEcCtD
Estropipate—Infection—Methotrexate—systemic scleroderma	0.000109	0.000447	CcSEcCtD
Estropipate—Nervous system disorder—Methotrexate—systemic scleroderma	0.000108	0.000442	CcSEcCtD
Estropipate—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000108	0.000441	CcSEcCtD
Estropipate—Skin disorder—Methotrexate—systemic scleroderma	0.000107	0.000437	CcSEcCtD
Estropipate—Urticaria—Prednisone—systemic scleroderma	0.000105	0.000428	CcSEcCtD
Estropipate—Abdominal pain—Prednisone—systemic scleroderma	0.000104	0.000426	CcSEcCtD
Estropipate—Body temperature increased—Prednisone—systemic scleroderma	0.000104	0.000426	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.0001	0.00041	CcSEcCtD
Estropipate—Insomnia—Methotrexate—systemic scleroderma	9.97e-05	0.000407	CcSEcCtD
Estropipate—Paraesthesia—Methotrexate—systemic scleroderma	9.9e-05	0.000404	CcSEcCtD
Estropipate—Somnolence—Methotrexate—systemic scleroderma	9.8e-05	0.0004	CcSEcCtD
Estropipate—Hypersensitivity—Prednisone—systemic scleroderma	9.72e-05	0.000397	CcSEcCtD
Estropipate—Dyspepsia—Methotrexate—systemic scleroderma	9.7e-05	0.000396	CcSEcCtD
Estropipate—Gastrointestinal disorder—Methotrexate—systemic scleroderma	9.52e-05	0.000389	CcSEcCtD
Estropipate—Fatigue—Methotrexate—systemic scleroderma	9.5e-05	0.000388	CcSEcCtD
Estropipate—Asthenia—Prednisone—systemic scleroderma	9.46e-05	0.000387	CcSEcCtD
Estropipate—Pain—Methotrexate—systemic scleroderma	9.43e-05	0.000385	CcSEcCtD
Estropipate—Pruritus—Prednisone—systemic scleroderma	9.33e-05	0.000381	CcSEcCtD
Estropipate—Diarrhoea—Prednisone—systemic scleroderma	9.02e-05	0.000369	CcSEcCtD
Estropipate—Gastrointestinal pain—Methotrexate—systemic scleroderma	9.01e-05	0.000368	CcSEcCtD
Estropipate—Urticaria—Methotrexate—systemic scleroderma	8.76e-05	0.000358	CcSEcCtD
Estropipate—Dizziness—Prednisone—systemic scleroderma	8.72e-05	0.000356	CcSEcCtD
Estropipate—Body temperature increased—Methotrexate—systemic scleroderma	8.71e-05	0.000356	CcSEcCtD
Estropipate—Abdominal pain—Methotrexate—systemic scleroderma	8.71e-05	0.000356	CcSEcCtD
Estropipate—Vomiting—Prednisone—systemic scleroderma	8.39e-05	0.000343	CcSEcCtD
Estropipate—Rash—Prednisone—systemic scleroderma	8.32e-05	0.00034	CcSEcCtD
Estropipate—Dermatitis—Prednisone—systemic scleroderma	8.31e-05	0.000339	CcSEcCtD
Estropipate—Headache—Prednisone—systemic scleroderma	8.26e-05	0.000338	CcSEcCtD
Estropipate—Hypersensitivity—Methotrexate—systemic scleroderma	8.12e-05	0.000332	CcSEcCtD
Estropipate—Asthenia—Methotrexate—systemic scleroderma	7.91e-05	0.000323	CcSEcCtD
Estropipate—Nausea—Prednisone—systemic scleroderma	7.83e-05	0.00032	CcSEcCtD
Estropipate—Pruritus—Methotrexate—systemic scleroderma	7.8e-05	0.000319	CcSEcCtD
Estropipate—Diarrhoea—Methotrexate—systemic scleroderma	7.54e-05	0.000308	CcSEcCtD
Estropipate—Dizziness—Methotrexate—systemic scleroderma	7.29e-05	0.000298	CcSEcCtD
Estropipate—Vomiting—Methotrexate—systemic scleroderma	7.01e-05	0.000286	CcSEcCtD
Estropipate—Rash—Methotrexate—systemic scleroderma	6.95e-05	0.000284	CcSEcCtD
Estropipate—Dermatitis—Methotrexate—systemic scleroderma	6.94e-05	0.000284	CcSEcCtD
Estropipate—Headache—Methotrexate—systemic scleroderma	6.9e-05	0.000282	CcSEcCtD
Estropipate—Nausea—Methotrexate—systemic scleroderma	6.55e-05	0.000267	CcSEcCtD
